NEW YORK, Oct 5 – Erik Wallden, president and CEO of Pyrosequencing of Uppsala, Sweden, said Thursday his company planned to leverage its sequencing technology to create kits that could eventually be used for clinical diagnostic purposes.

“We would be providing the techniques to sequence small-sized pieces of DNA and we would either license the technology or manufacture the kits,” Wallden told GenomeWeb. He did not say when the clinical diagnostic kit would be available for commercialization.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.